KURA logo

Kura Oncology (KURA) Company Overview

Profile

Full Name:

Kura Oncology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 16, 2015

Indexes:

Not included

Description:

Kura Oncology is a biopharmaceutical company focused on developing targeted therapies for cancer. They aim to improve treatment options for patients with various types of cancer by creating innovative drugs that specifically attack cancer cells while minimizing harm to healthy cells.

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 6, 25 Wedbush
Outperform
Feb 6, 25 JMP Securities
Market Outperform
Feb 6, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Scotiabank
Sector Perform
Dec 9, 24 Cantor Fitzgerald
Overweight
Nov 26, 24 Cantor Fitzgerald
Overweight
Nov 22, 24 B of A Securities
Buy
Nov 21, 24 TD Cowen
Buy
Nov 21, 24 Jefferies
Buy
Nov 21, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kura Oncology?
  • Does Kura Oncology pay dividends?
  • What sector is Kura Oncology in?
  • What industry is Kura Oncology in?
  • What country is Kura Oncology based in?
  • When did Kura Oncology go public?
  • Is Kura Oncology in the S&P 500?
  • Is Kura Oncology in the NASDAQ 100?
  • Is Kura Oncology in the Dow Jones?
  • When was Kura Oncology's last earnings report?
  • When does Kura Oncology report earnings?
  • Should I buy Kura Oncology stock now?

What is the ticker symbol for Kura Oncology?

The ticker symbol for Kura Oncology is NASDAQ:KURA

Does Kura Oncology pay dividends?

No, Kura Oncology does not pay dividends

What sector is Kura Oncology in?

Kura Oncology is in the Healthcare sector

What industry is Kura Oncology in?

Kura Oncology is in the Biotechnology industry

What country is Kura Oncology based in?

Kura Oncology is headquartered in United States

When did Kura Oncology go public?

Kura Oncology's initial public offering (IPO) was on September 16, 2015

Is Kura Oncology in the S&P 500?

No, Kura Oncology is not included in the S&P 500 index

Is Kura Oncology in the NASDAQ 100?

No, Kura Oncology is not included in the NASDAQ 100 index

Is Kura Oncology in the Dow Jones?

No, Kura Oncology is not included in the Dow Jones index

When was Kura Oncology's last earnings report?

Kura Oncology's most recent earnings report was on Nov 7, 2024

When does Kura Oncology report earnings?

The next expected earnings date for Kura Oncology is Feb 27, 2025

Should I buy Kura Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions